US 12083229
Ocular drug delivery formulation
granted A61KA61K31/192A61K31/658
Quick answer
US patent 12083229 (Ocular drug delivery formulation) held by INMED PHARMACEUTICALS INC. expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- INMED PHARMACEUTICALS INC.
- Grant date
- Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/192, A61K31/658, A61K9/0048, A61K9/5153